# Tim Illidge

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tim-illidge/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,016 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 64 |
| i10-index | 166 |
| Last Known Institution | Manchester Academic Health Science Centre |
| OpenAlex ID | https://openalex.org/A5079281059 |
| ORCID iD | https://orcid.org/0000-0003-3191-7324 |
| Works | 405 |

## Researcher papers

- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group](https://scholariq.org/papers/modern-radiation-therapy-for-primary-cutaneous-lymphomas-field-and-dose/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [Manchester Academic Health Science Centre](https://scholariq.org/institutions/manchester-academic-health-science-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.